RADIONUCLIDE IMAGING OF INFECTIVE ENDOCARDITIS: state of art and future perspective by MARCHETTA, Stella et al.
CARDIAC NUCLEAR IMAGING (A CUOCOLO AND M PETRETTA, SECTION EDITORS)
Radionuclide Imaging of Infective Endocarditis: State of Art
and Future Perspective
Stella Marchetta1 & Nadia Withofs2 & Paola Anna Erba3 & Gilbert Habib4,5 &
Roland Hustinx2 & Patrizio Lancellotti1,6,7
# Springer Science+Business Media, LLC 2017
Abstract
Purpose of Review Infectious endocarditis is a serious disease
requiring rapid diagnosis and accurate risk stratification to
offer the best therapeutic strategy. Infection of prosthetic valve
(PV) and cardiovascular implantable electronic device (CIED)
is increasing due to the ageing of the population and the grow-
ing number of implants. Foreign material infection remains
clinically challenging given the limitation of ultrasound tech-
niques in this context whereas the diagnosis must be
precocious.
Recent Findings 18F-fluorodeoxyglucose positron emission
tomography/computed tomography ([18F]FDG PET/CT) and
radiolabelled leukocytes single-photon emission computed
tomography/computed tomography (SPECT/CT) are com-
monly used for this purpose.
Summary In the present article, we summarized the available
evidence for the use of nuclear imaging for the evaluation of
infectious endocarditis.
Keywords Infective endocarditis . Cardiac prosthetic valves .
Cardiovascular implantable electronic device . [18F]FDG
positron emission tomography . Radiolabelled leukocyte
scintigraphy . Embolic events
Introduction
Infective endocarditis (IE) remains a deadly disease despite con-
tinuous advances inmedical and surgical management [1–3, 4••].
In the recent years, epidemiology of IE has undergone significant
changes with increasing number of elderly patients presenting
with degenerative valvular disease, nosocomial infections, or
device-related IE (prosthetic valves (PV), cardiac implantable
electronic devices (CIED)). Though the diagnosis of IE remains
challenging, the main advantage of timely diagnosis is the poten-
tial to prevent complications such as embolic events, septic com-
plications, and valvular destruction [1]. In daily practice, the
diagnosis of IE relies on the modified Duke criteria that use
typical clinical signs and symptoms and positive blood cultures
to reach a definitive diagnosis when the valve/device can be
shown to be affected on echocardiography (vegetation, abscess
or pseudoaneurysm, and new PV dehiscence). However, this
technique has a sensitivity and specificity of approximately
80% for native valve endocarditis (NVE) [2]. The diagnostic
accuracy is even lower for PVE [3] or CIED infection [4••], in
which echocardiography gives uncertain results in up to 30% of
cases. The major drawbacks of transthoracic (TTE) and
transoesophageal (TOE) echocardiography are related to patient
morphology, instrumental settings, transducer position, operator
skill, artefacts secondary to calcifications and reverberations of
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metallic structures, and the disease course (less accurate in the
early stage) [5]. The shortcomings of the diagnosis of IE based
on morphological changes have triggered an increasing use of
functional imaging (18F-fluorodeoxyglucose ([18F]FDG) posi-
tron emission tomography (PET) and radiolabelled leukocytes
single-photon emission computed tomography (SPECT)) for
the evaluation of the metabolic activity caused by the infection,
prior to any structural (morphological) change. When combined
with standard diagnostic tests, functional imaging procedures
have been shown to reduce the rate of misdiagnosed cases of
IE. The recent European Society of Cardiology (ESC) guidelines
have incorporated molecular imaging in the diagnostic work-up
of PVE, whereas in case of CIED infection, the indication is less
supported by the literature (recommendation class IIB level of
evidence C) [1]. According to the new guidelines, the finding of
abnormal [18F]FDG or radiolabelled leukocyte uptake around
PV represents a major Duke criterion, whilst an embolic event
or infectious aneurysms detected by imaging represents a minor
criterion. All this has highlighted the major role of the imaging
specialists as part of the ‘Endocarditis Team’, in the management
of IE. In the present article, we summarized the available evi-
dence for the use of nuclear imaging for the evaluation of IE.
[18F]FDG PET/CT and Radiolabelled White Blood Cell
(WBC) SPECT/CT
[18F]FDG PET/CT is a non-invasive imaging technique
evaluating the metabolic activities of healthy and patho-
logical tissues. [18F]FDG is a glucose analogue, which is
incorporated by cells with enhanced expression of the
glucose transporters (GLUT 1 and GLUT 3), as in pres-
ence of activated leukocytes, macrophages and CD4+
lymphocytes. Once in the cytoplasm, [18F]FDG is phos-
phorylated and trapped into the cells [6••]. By the combi-
nation of [18F]FDG PET and high-resolution computed
tomography (CT), the functional information and the an-
atomical details are entailed in single image [7]. Whole-
body PET/CT is performed using a single acquisition
time-point, generally 45–60 min after intravenous injec-
tion of [18F]FDG, with an emission time/bed position de-
pending on the sensitivity of the scanner. The field of
acquisition is usually derived from oncology studies from
skull base to mid thighs. The majority of PET/CT studies
consists of a protocol comprising a scanogram/scout
scan/topogram and CT-AC. The simultaneous acquisition
of a standard diagnostic CT scan with intravenous contrast
agent is possible. PET images are visually evaluated to
search for area of increased [18F]FDG uptake, taking into
consideration the pattern (focal, linear, diffuse), intensity,
and relationship to areas of physiologic distribution. PET
information is compared with morphologic information
obtained by CT. Semi-quantitative analysis by maximal
standardized uptake value (SUVmax) or other semi-
quantitative parameters is also possible. However, SUV
has not been validated in infection [8•]. When [18F]FDG
PET/CT is used to diagnose cardiac and pericardiac infec-
tion, patient preparation becomes very important due to
the possible presence of physiologic uptake of [18F]FDG
in normal myocardium (for details about this topic, see
the Addendum). The current SNMMI/ASNC/SCCT
guidelines recommend preparation with a fat-enriched diet
lacking carbohydrates for 12–24 h prior to the scan, a 12–
18 h fast, and/or the use of intravenous heparin approxi-
mately 15 min prior to [18F]FDG injection [9]. To prevent
misinterpretation of a positive scan due to early imaging
after valve implantation, the ESC Guidelines recommend
not to consider [18F]FDG PET results in the 3-month pe-
riod following prosthetic heart valve (PHV) implantation
[5] (Table 1).
White blood cell (WBC) SPECT/CT imaging uses au-
tologous radiolabelled leukocytes after radiolabelling with
111In-oxine and 99mTc-hexamethylpropyleneamine oxime
(HMPAO). Imaging acquisition protocol includes planar
acquisitions at 30 min (early images), 4–6 h (delayed im-
ages) and 20–24 h (late images) after reinjection of 99mTc-
HMPAO/111In-oxine-WBC. A SPECT/CT acquisition is
mandatory as part of the standard imaging protocol, and
it is usually acquired at 4–6 h and/or at 20–24 h p.i. 99mTc-
HMPAO is preferred because more available, provides
better image quality with lower patients radiation burden
[6, 10•]. The interpretation of WBC scintigraphy should
always begin with a visual quality control performed on
WB images and chest planar acquisitions. The signal ki-
netics between 4 and 6 h and 20–24 h acquisitions is an
important feature for interpretation: any stable-increased
uptake intensity or size over time, confirmed at SPECT/
CT, is highly suggestive of infection (Table 1).
Native Valve Endocarditis
In native valve endocarditis (NVE), the usefulness of func-
tional nuclear imaging has yet to be demonstrated. Indeed,
few studies evaluated this specific clinical setting. In a recent
prospective study concerning 72 patients with bacteraemia
(Staphylococcus, Streptococcus species and Enterococcus
species), Kouijzer et al. reported a limited accuracy (sensitiv-
ity 39%, specificity was 93%) of [18F]FDG PET/CT for diag-
nosing IE. Only two patients had PVin this study [11••]. Other
smaller studies did not show better results [12••] (Table 2).
Nevertheless, this technique may allow early detection
of metastatic infectious disease with a high sensitivity
(87–100%) and specificity (80%) [12••], at a reasonable
cost-effectiveness, especially in patients with Gram-
positive bacteraemia [13•].
99m TC-HMPAO WBC SPECT/CT has been used by
Erba et al. in a mixed population (16 NVE and 35
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PVE) showing that no cases were undiagnosed when
either the echography or the blood cultures were posi-
tive [14••] (Table 2) (Fig. 1).
Prosthetic Valve Endocarditis
The rate of prosthetic valve endocarditis (PVE) ranges from 1–6
to 15%, being higher in revision surgery [15]. Conversely to
NVE, which is usually limited to the presence of a vegetation,
PVE infection generally spread along the sewing ring and leads
to peri-annular extension (pseudo-aneurysms, abscess) [16]. In a
recent prospective study concerning 72 patients, Saby et al.
showed that adding abnormal 18F-FDG uptake around a PV to
the modified Duke criteria at admission increased the sensitivity
for definite PVE from 70 to 97% (Table 2) [17••]. This result was
due to a significant reduction in the number of possible PVE
cases from 56 to 32%. In addition, [18F]FDG PET/CT allowed
detection of valvular damage before ultrasounds [8, 18]. Other
smaller studies also confirmed these data [12]. More recently,
Pizzi et al. reported the incremental value of [18F]FDG PET/
CT imaging in association with CT-angiography (CTA) over
the modified Duke score at admission for the diagnosis of IE in
75 patients with PVor intra-cardiac devices. [18F]FDGPET/CTA
offered excellent diagnostic performances (sensitivity 87%, spec-
ificity 90%) for the detection of IE. [18F]FDG PET/CTA in as-
sociationwithDuke criteria allowed reclassifying 90% (35/39) of
cases initially classified as ¨possible¨ IE and provided a more
conclusive diagnosis (definite/reject) in 95% (71/75) of cases
(Table 2). Besides, [18F]FDGPET/CTA identified a greater num-
ber of anatomic lesions than PET/CTor echocardiography, many
of them relevant for clinical and surgical decision-making
(pseudoaneurysms, fistulas, thrombosis and coronary involve-
ment) [18].
A clear advantage of CTA in IE patients is the ability to assess
the entire chest (identification of septic pulmonary infarcts and
abscesses), the aorta and the coronary arteries before contemplat-
ed surgery [18••]. Several reports have also highlighted the po-
tential added value of radiolabelled leukocytes SPECT/CT in the
diagnosis of PVE (sensitivity 64–90%, specificity 36–100%),
even in the early post-intervention phase [14, 19•]. As for
[18F]FDG PET/CT, 99mTc-WBC SPECT/CT has an excellent
positive predictive value for the detection of perivalvular infec-
tion and abscesses in patients with a suspicion of PVE. In addi-
tion, the intensity of radiolabelled leucocyte accumulation in the
perivalvular area detected with scintigraphy represents an inter-
esting marker of local infectious activity and extension. Patients





■ Higher spatial resolution compared with SPECT
■ Fast images acquisition (80 min with 60 min preparation
and 20 min scan time)
■ Decreases cases of “possible IE” and rise-up so-called
“defined” endocarditis in PVE and CIED
■ Helps in the diagnosis of deep, superficial or lead in
pacemaker’s infection
■ Seems to be promising in diagnosis LVAD related infection
■ Detects paravalvular lesions & extracardiac complications
(even silent events)
■ Detects other sources of fever and/or neoplasia in a single
time
■ Seems demonstrating valvular damage before ultrasounds
■When combined with CTA, provides high spatial
resolution images to identify structural damage and
analyse the coronary artery
■ Radiation exposure: effective dose ~8 mSv (4 mSv for an injected dose
of 210 MBq 18F–FDG and ~4 mSv for the low dose CT a
■ Poor accuracy with NVE
■ Cannot differentiate infectious from non infectious inflammation and
not reliable within 3 months postoperatively for PVE and 6 weeks for
CIED
■ No standardized protocols for preparation of patients and acquisition of
images − dietary restriction − test uninterpretable in areas with high
background activity such as heart when high myocardial uptake
■ Artefacts with heartbeat and breathing
■ Possible false-negatives test in patients with small vegetation (<6 mm)
and prolonged antibiotic therapy
■ Possible false-positives in active thrombi, cardiac tumours or metastasis,
foreign body reactions, atrial fibrillation and lipomatous hypertrophy




■ High positive predictive value and specificity for acute
infection: useful in direct post-operative
■ Helps to detect abscesses and paravalvular infections
■Helps for detecting septic embolism even in asymptomatic
patients
■ No false-positives in cardiac infection
■ Later SPECT images acquisition possible with 111In-oxine
labelled leukocytes, valuable in low-grade infection
■ Radiation exposure higher effective dose with 111In-oxine- labelled
WBC (~ 11 mSv) than with 99mTc-HMPAO-labelledWBC (~ 3 mSv) a
■ Limited spatial resolution
■May require later images acquisition (24 h with four visits and 2 scans)
and multiple appointments
■ Artefacts of metal
■ Handling of blood products
■ False-negatives with Enterococcus and Candida infections
(nonpyogenic microorganisms)
■ Effect of antibiotherapy unclear
■ False-positives and false-negatives regarding distant septic embolisms
■ Requires special equipment and not available in several centres & costly
a Effective dose calculated in an adult male using the “NuclearMedicine RadiationDose Tool” of the Society of nuclear medicine andmolecular imaging
available at http://www.snmmi.org/ClinicalPractice/doseTool.aspx?ItemNumber=11216&navItemNumber=11218
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with a mild activity on the first exam disappearing on the second
imaging evaluation seem to have a favourable outcome [19•]
(Fig. 2).
Cardiac Device-Related IE
Cardiac device-related IE (CDRIE)—infection extending to the
electrode leads, cardiac valve leaflets, or endocardial surface—
should be distinguished from local device infection (pocket/gen-
erator). An incidence of 1.4 per 1000 device-years of definite
CDRIE has been reported [3]. As for PV, 99mTc-WBC SPECT/
CT and [18F]FDG PET/CT are able to differentiate CDRIE from
post-implantation changes (i.e., pocket hematoma) and to char-
acterize the extension of the infectious process (Fig. 3).
[18F]FDG PET/CT diagnoses pocket infection with a good sen-
sitivity (87–91%) and specificity (93–100%). The use of func-
tional nuclear imaging can, therefore, allow the distinction be-
tween superficial and deep pocket infection, which necessitates
removal of the generator rather than a medical treatment [21•].
The diagnostic accuracy of [18F]FDGPET/CT for lead infections
is, however, lower (sensitivity 24–100%, specificity 79–100%)
[12]. Such a finding is mainly related to the small size of the
vegetations along the leads, which are often under the spatial
resolution of the system [20]. [18F]FDG PET/CT in association
with Duke criteria also allowed reclassifying most of cases ini-
tially classified as ¨possible¨ IE [18]. Erba et al. also reported a
good diagnostic accuracy (94%) of 99m TC-HMPAO WBC
SPECT/CT for CIED infection and for distinguishing infection
Fig. 1 To the left of the picture, transophagic ultrasound showing
massive mitral endocarditis on native valve (a standard sections; b 3D
sections). To the right of the picture (c), 18F-FDG PET/CT images (from
left to right; coronal slice, sagittal slice, axial slice) of a patient with a
native mitral valve endocarditis (red arrows, SUVmax: 4.4)
Fig. 2 To the left of the picture, transoephagic ultrasound of a mitral
prosthesis revealing no obvious anomaly. To the right, [18F]FDG PET/
CT images (a coronal slice; b sagittal slice; c axial slice) of a patient with a
PVE showing two foci of FDG uptake in the prosthetic mitral valve (red
arrows, SUVmax: 4.4; purple arrows, SUVmax 3.5)
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limited to the pocket or leads from a more severe infection af-
fecting the whole device [23] (Table 2). Therefore, both imaging
approaches can be of help in patients with suspected CDRIE
(ESC class IIb recommendations) [5].
Detection of Metastatic Infectious Events
Embolic events are a frequent and life-threatening complication
of IE. They occur in 20–50% of patients and can be totally silent
in 20–50%of cases. The brain and spleen are themost affected in
the left IE while the lungs complicate the right IE, particularly in
CDRIE [5]. In the recent ESC guidelines, the imaging detection
of septic emboli clearly impacts on the Duke score and conse-
quently on the diagnostic certainty of IE (minor criterion) and
decision-making. In fact, as reported by several authors,
[18F]FDG PET/CT is capable of detecting distant embolic sites
(15%) with a reasonable sensitivity (14–100%) and specificity
(80%), most of which clinically silent (up to 30%), and previ-
ously undiagnosed tumours (6.5%), many of them in early stages
and potentially curable [12, 24]. This approach is relatively cost-
effective and may avoid using additional ionizing radiologic
techniques. [18F]FDG PET/CT is very accurate in organs with
low physiological uptake, therefore not applicable in ruling out
the presence of brain embolism [25•]. Radiolabelled leukocytes
SPECT/CT shares with PET/CT the possibility of acquiring
whole-body images and by performing additional planar and
SPECT/CT spot images also constitutes an invaluable aid for
detecting septic embolism even in asymptomatic patients [14,
23•].
Left Ventricular Assist Device Associated Infections
The prevalence of infection and sepsis in left ventricular assist
device (LVAD) patients ranges from 23 to 58%, being associated
with a high mortality rate (15–44%) [26]. The major sites of
infection comprise the mediastinum drivelines and device sur-
face, so called « LVAD endocarditis » [27]. In a recent retrospec-
tive study concerning 31 patients, [18F]FDG PET/CT yielded a
sensitivity of 100% and a specificity of 94% for the diagnosis of
LVAD infection [28]. Litzler et al. also highlighted the potential
usefulness of radiolabelled leukocytes SPECT/CT in the man-
agement of LVAD infection (8 patients) by determining the pre-
cise anatomic location and extent of a suspected infection [26].
The evidence in this setting is, however, still quite limited.
Limitations and Technical Considerations
Despite significant advantages, molecular imaging techniques
still present limitations that would require further developments
(Table 1). The majority of them are related to the complexity of
imaging interpretation, particularly when [18F]FDG is used. In
fact, several pathological conditions can mimick the pattern of
focally increased uptake such as non-infected tissue (active
thrombi, atherosclerotic plaques, vasculitis, tumours, lipomatous
hypertrophy of the inter-atrial septum, foreign body reactions (i.e.
BioGlue surgical adhesive used to seal the aortic graft at time of
surgery)). Timing of imaging in relation to surgical intervention
still remains an open issue since up to 4–8 weeks, the persistence
of post-operative inflammatory response with false positive re-
sults is possible. Clear definition of the impact of antimicrobial
treatment (risk of false negative cases) as well as of blurring
artefacts has also to be established. In addition, the problem of
false negative results in presence of small oscillating vegetation
and metastatic foci <5 mm which are below the threshold of
detectability/resolution has to be considered as well as the issue
of radiation burden that might increase when certain protocol for
imaging acquisition are applied (i.e. retrospective ECG-trigger-
ing) [6, 29].
The best strategy to reduce false positive finding is correct
patient preparation and selection. We want to underline, once
Fig. 3 To the left of the picture, transoesophageal ultrasound of a patient
with a pacemaker suffering from a fever of undetermined origin; absence
of obvious lesion identified. To the right of the picture, [18F]FDG PET/CT
images (a maximum intensity projection of PET images; b,c axial slices)
of a patient with a CIED. Images show a focus of FDG uptake in
pacemaker leads in the superior vena cava (a, b red arrows, SUVmax
4.7) and a FDG avid reactive lymph node in the mediastinum (a, c green
arrows, SUVmax 5.4)
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more, how important is the optimal suppression of physiologic
myocardial glucose utilization with (1) high fat, low carbohy-
drate diet for at least two meals with a fast of at least 4 h prior
imaging [24, 30•]; (2) possible use of intravenous unfractionated
heparin (50 IU/kg) approximately 15 min prior to 18F-FDG in-
jection [16, 31]. In addition, we also recommend to withdraw of
metformin which is associated with intense and diffuse
[18F]FDG uptake in the small and large bowels [32•]; (3)
discontinuation/reduction to the lowest possible dose the use of
steroid in the 24 h preceding the exam [32•]; (4) avoid the inclu-
sion of patients <3 months of PV implantation [5].
Of note, neither diabetes nor hyperglycemia at the time of
the study seems to increase the false-negative rate; a blood
glucose level below 200 mg/dL might be suggested [32]. At
this stage, there is no evidence to routinely recommend anti-
microbial treatment discontinuation before performing
[18F]FDG PET/CT. However, the use of antimicrobial should
be taken into account during imaging interpretation since they
might affect the intensity of FDG uptake due to their immu-
nomodulatory effect [7]. Late PET/CT imaging (2–3 h after
FDG injection) should be considered in patients when nega-
tive 1-h PET/Ct scan in maximizing the contrast between sep-
tic foci and background [33].
As compared to [18F]FDG PET/CT, radiolabelled leukocyte
imaging is more time consuming, necessitates in-house leuko-
cytes labelling with direct handling of blood products, requiring
specific experience (and should be performed in trained centres)
[19, 32•, 34•]. As for [18F]FDG PET, the major goals of
radiolabelled leukocytes SPECT/CT are to minimize tracer up-
take in normal tissues, while maintaining uptake in target tissues.
False positive findings have been described in distant septic
embolisms (cold spot in spleen/kidney embolism or
spondylodiskitis; hot spot in benign or malign process) but not
in cardiac infection [14]. False negative scans have been ob-
served (1) in patients with small valve vegetation (<6 mm, limit
of spatial resolution), (2) in case of IE by some strains
Fig. 4 Proposed algorithm
incorporating nuclear imaging
and current guidelines in
diagnosis IE [1, 6••]
Curr Cardiovasc Imaging Rep  (2017) 10:27 Page 7 of 9  27 
(Staphylococcus epidermidis, Enterococcus, Candida, Coxiella
burnetii) able to form a biofilm limiting neutrophil recruitment
at the primary site of IE and the local efficacy of antimicrobial
treatment, (3) in case of drained abscess [14, 32•]. Of note, the
impact of antibiotic therapy has not been specifically examined.
Perspectives and Future Developments
The ideal molecular imaging modality would allow for a reli-
able detection of infection at an early stage, differentiate infec-
tion from other causes of inflammation, provide species
(causative micro-organism) and resistance information to guide
optimal therapy and monitor disease progression, contribute to
shorten the hospital stay, prevent clinical complications, and
reduce the cost of hospitalization. Such an imaging modality
would require discovery of pathogenic mechanisms that can
serve as imaging targets (i.e. fibrin, platelet, granulocytes,
etc.), development and validation of new pathogen-specific
probes (bacteria-targeted imaging approaches), and implemen-
tation of technologies that are capable of specific IE detection
(targeted molecular imaging), combine molecular imaging to
anatomical imaging with high soft-tissue contrast such as PET/
MRI (magnetic resonance imaging) and/or providing detectors
with higher sensitivity and spatial resolution (i.e. digital PET/
CT and cadium-zinc-telluride camera) [35, 36].
Conclusion
Functional nuclear imaging has gained growing interest in
the diagnos is and management of IE (Fig . 4) .
Radiolabelled leukocyte SPECT/CT seems to be more
specific for the detection of IE and infectious foci than
18F-FDG [18F]FDG PET/CT. Nevertheless, [18F]FDG
PET/CT is likely the preferred first-line metabolic imag-
ing technique since SPECT/CT is less sensitive, more
time consuming and require in-house leukocyte labelling.
Radiolabelled leukocytes could be reserved for doubtful
cases with PET/CT. Nonetheless, radiolabelled leukocytes
could be particularly useful in early post-operative period
and in NVE. Further research should focus on defining
the best protocol and the ideal timing for image acquisi-
tion and on the development of more specific probes.
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